A detailed history of Concurrent Investment Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 117,290 shares of MRK stock, worth $11.9 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
117,290
Previous 113,061 3.74%
Holding current value
$11.9 Million
Previous $14 Billion 4.84%
% of portfolio
0.39%
Previous 0.46%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$111.15 - $128.97 $470,053 - $545,414
4,229 Added 3.74%
117,290 $13.3 Billion
Q2 2024

Jul 30, 2024

BUY
$123.8 - $132.96 $3.73 Million - $4.01 Million
30,165 Added 36.39%
113,061 $14 Billion
Q1 2024

May 07, 2024

SELL
$113.24 - $131.95 $282,420 - $329,083
-2,494 Reduced 2.92%
82,896 $10.9 Billion
Q4 2023

Apr 15, 2024

BUY
$100.18 - $109.02 $8.55 Million - $9.31 Million
85,390 New
85,390 $9.31 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.